Trial NCT02435836

View at ClinicalTrials.gov 
Org. Study IDs: 31-97-303

Last trial update was posted on 2015-09-21

MeSH Interventions

Aripiprazole

MeSH Conditions

Schizophrenia

Other Conditions


Stopping Reasons

Study terminated when aripiprazole available commercially per protocol

Limitations And Caveats

The study was terminated prematurely by the sponsor. The protocol specified that the study would run until Abilify (aripiprazole) was commercially available in all site countries.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID